Pipeline
Denifanstat Pipeline on Multiple Indications and Clinical Milestones
![](http://sagimet.com/wp-content/uploads/2024/03/Captura-de-tela-2024-03-06-192721.png)
Therapeutic area
Indication
Preclinical
Phase 1
Phase 2
Phase 3
TVB-2640
TVB-3567
* Trials conducted in China by Ascletis, who has licensed development and commercialization rights to all indications in Greater China